CYR61 polymorphisms are associated with plasma HDL-cholesterol levels in obese individuals

Clinical Genetics

Volumn 72, Issue 3, 2007, Pages 224-229

  Bouchard, L ^a,b   Tchernof, A ^a,b   Deshaies, Y ^a   Lebel, S ^c   Hould, F S ^c   Marceau, P ^c   Vohl, Marie Claude ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE RICH PROTEIN 61; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHI SQUARE TEST; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; GENE FREQUENCY; GENE LOCUS; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INTRON; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CHOLESTEROL, HDL; FEMALE; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 34548138899     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2007.00855.x     Document Type: Article

References (28)

1. Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic syndrome: A global public health problem and a new definition. J Atheroscler Thromb 2005: 12: 295-300.
2. Bouchard C. Genetics and the metabolic syndrome. Int J Obes Relat Metab Disord 1995: 19 (Suppl. 1): S52-S59.
3. Rice T, Nadeau A, Pérusse L, Bouchard C, Rao DC. Familial correlations in the Quebec family study: Cross-trait familial resemblance for body fat with plasma glucose and insulin. Diabetologia 1996: 39: 1357-1364.
4. Pérusse L, Rice T, Despres JP, Rao DC, Bouchard C. Cross-trait familial resemblance for body fat and blood lipids: Familial correlations in the Quebec Family Study. Arterioscler Thromb Vasc Biol 1997: 17: 3270-3277.
5. Bouchard L, Tchernof A, Deshaies Y et al. ZFP36: A promising candidate gene for obesity-related metabolic complications identified by converging genomics. Obes Surg 2007: 17: 372-382.
6. Jay P, Berge-Lefranc JL, Marsollier C, Mejean C, Taviaux S, Berta P. The human growth factor-inducible immediate early gene, CYR61, maps to chromosome 1p. Oncogene 1997: 14: 1753-1757.
7. Brigstock DR. The CCN family: A new stimulus package. J Endocrinol 2003: 178: 169-175.
8. Brigstock DR. Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61). Angiogenesis 2002: 5: 153-165.
9. Schror K, Hohlfeld T. Mechanisms of anti-ischemic action of prostaglandin E1 in peripheral arterial occlusive disease. VASA 2004: 33: 119-124.
10. Schwarz DA, Barry G, Mackay KB et al. Identification of differentially expressed genes induced by transient ischemic stroke. Brain Res Mol Brain Res 2002: 101: 12-22.
11. Hilfiker A, Hilfiker-Kleiner D, Fuchs M et al. Expression of CYR61, an angiogenic immediate early gene, in arteriosclerosis and its regulation by angiotensin II. Circulation 2002: 106: 254-260.
12. Vohl M, Sladek R, Robitaille J et al. A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men. Obesity Research 2004: 12: 1217-1222.
13. Robitaille J, Despres JP, Perusse L, Vohl MC. The PPAR-gamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: Results from the Quebec Family Study. Clin Genet 2003: 63: 109-116.
14. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001: 25: 402-408.
15. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) (Adult Treatment Panel III). JAMA 2001: 285: 2486-2497.
16. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005: 21: 263-265. Epub 2004 August 5.
17. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001: 68: 978-989. Epub 2001 March 9.
18. Stephens M, Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003: 73: 1162-1169. Epub 2003 October 20.
19. Faraj M, Lu HL, Cianflone K. Diabetes, lipids, and adipocyte secretagogues. Biochem Cell Biol 2004: 82: 170-190.
20. Heilbronn L, Smith SR, Ravussin E. Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus. Int J Obes Relat Metab Disord 2004: 28 (Suppl. 4): S12-S21.
21. Smith J, Al-Amri M, Dorairaj P, Sniderman A. The adipocyte life cycle hypothesis. Clin Sci (Lond) 2006: 110: 1-9.
22. Babic AM, Kireeva ML, Kolesnikova TV, Lau LF. CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci U S A 1998: 95: 6355-6360.
23. Mo FE, Muntean AG, Chen CC, Stolz DB, Watkins SC, Lau LF. CYR61 (CCN1) is essential for placental development and vascular integrity. Mol Cell Biol 2002: 22: 8709-8720.
24. Sarmiento U, Benson B, Kaufman S et al. Morphologic and molecular changes induced by recombinant human leptin in the white and brown adipose tissues of C57BL/6 mice. Lab Invest 1997: 77: 243-256.
25. Sierra-Honigmann MR, Nath AK, Murakami C et al. Biological action of leptin as an angiogenic factor. Science 1998: 281: 1683-1686.
26. Morange PE, Lijnen HR, Alessi MC, Kopp F, Collen D, Juhan-Vague I. Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity. Arterioscler Thromb Vasc Biol 2000: 20: 1150-1154.
27. Schafer K, Fujisawa K, Konstantinides S, Loskutoff DJ. Disruption of the plasminogen activator inhibitor 1 gene reduces the adiposity and improves the metabolic profile of genetically obese and diabetic ob/ob mice. FASEB J 2001: 15: 1840-1842.
28. Lijnen H, Maquoi E, Morange P et al. Nutritionally induced obesity is attenuated in transgenic mice overexpressing plasminogen activator inhibitor-1. Arterioscler Thromb Vasc Biol 2003: 23: 78-84.